Current Clinical Trials
G-DISCO
Bladder — In Follow-up
If you think this trial might be right for you, please ask your doctor.
TRIAL TITLE
A Phase 1 study of feasibility, safety and tolerability of synchronous intravesical administration of gemcitabine and docetaxel
CONSUMER TITLE
Early-phase study testing whether giving two chemotherapy treatments (gemcitabine and docetaxel) directly into the bladder together is safe and well tolerated for people with bladder cancer.
CANCER TYPE
Bladder
TRIAL STATUS
In Follow-up
PROTOCOL NUMBER
ANZUP 2403
CO-ORDINATING CENTRE
STUDY CHAIR
Dickon Hayne, Cynthia Hawks
PATIENT POPULATION
Males and females aged 18 years and over who have fully resected high-risk non-muscle-invasive bladder cancer (HRNMIBC) that is unresponsive to intravesical therapy, an ECOG status of 0-2, a life expectancy of > 6 months, and adequate organ and bone marrow function.
RECRUITMENT TARGET
15 people
ACKNOWLEDGEMENT
The study is funded by a Below the Belt grant awarded by the Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group.